Bausch Health Co. Inc. (BHC) Q4 Revenue Tops Views, Guidance Misses at Mid-Point
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance
February 20, 2019 7:02 AM ESTLAVAL, Quebec, Feb. 20, 2019 /PRNewswire/ --
Fourth-Quarter 2018 Financial Results Revenues of $2.121 Billion GAAP Net Loss of $344 Million Adjusted EBITDA (non-GAAP)1 of $858 Million Full-Year 2018 Financial Results Revenues of $8.380 Billion GAAP Net Loss of $4.148 Billion Adjusted EBITDA (non-GAAP)1 of $3.474 Billion Delivered Full-Year Organic Revenue Growth1,2Â in 2018Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we") today... More
